Isotope-Labeled Compounds

WNK-IN-11-d3 is a selective and potent inhibitor of WNK kinases, designed for oral administration. This compound plays a crucial role in modulating cardiovascular homeostasis and serves as a valuable tool in studying cardiovascular signaling pathways and related conditions. Its unique mechanism of action makes it a significant reagent for research applications targeting WNK kinase-related processes.

Tyk2-IN-19-d6 is a deuterium-labeled inhibitor of Tyrosine Kinase 2 (Tyk2), a pivotal component of the JAK-STAT signaling pathway. This compound exhibits potent inhibition of Tyk2 activity, making it valuable for research in autoimmune diseases and cancer. Its unique deuterated structure facilitates pharmacokinetic studies and enhances the understanding of Tyk2-related biological processes.